Literature DB >> 28566616

Macro-CK and CK-BB Contributing to Sham CK-MB Elevation.

Yuki Wada1, Jun Tanigawa1, Nobukazu Ishizaka1.   

Abstract

Entities:  

Keywords:  CK-BB; CK-MB; macro-CK; malignancy

Year:  2017        PMID: 28566616      PMCID: PMC5498217          DOI: 10.2169/internalmedicine.56.8329

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
A 65-year-old man in whom an inferior vena cava filter had been implanted for deep vein thrombosis was admitted to the cardiology department due to appetite loss and lumbago. Laboratory data showed increased total creatinine kinase (CK, 796 U/L, Picture 1, left) and CK-MB (1,213 U/L), which exceeded the total CK value. Electrophoresis showed, in addition to an increase in CK-BB, a peak that migrated further toward the cathode than CK-MM, suggestive of macro-CK (Picture 1, right). Given the findings on magnetic resonance imaging, prostate cancer with spinal metastasis was suspected (arrows, Picture 2), which was confirmed by a histopathologic examination of the prostate. Macro-CK type 2, which is reported to be present in 0.5-3.7% of subjects, may be under-recognized (1). Considering that patients with elevated total CK and CK-MB are frequently referred to the cardiology department, cardiologists should not overlook this abnormal condition, as macro-CK and elevated CK-BB may be associated with malignancy (2).
Picture 1.
Picture 2.

The authors state that they have no Conflict of Interest (COI).
  2 in total

1.  A rare but important cause for a raised serum creatine kinase concentration: two case reports and a literature review.

Authors:  B Galarraga; D Sinclair; M N Fahie-Wilson; F C McCrae; R G Hull; J M Ledingham
Journal:  Rheumatology (Oxford)       Date:  2003-01       Impact factor: 7.580

2.  Serum CK-BB as a tumor marker in patients with carcinoma confirmed histologically.

Authors:  J Arenas; A E Diaz; M J Alcaide; I Santos; A Martínez; J M Culebras
Journal:  Clin Chim Acta       Date:  1989-06-30       Impact factor: 3.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.